U

UTI

UTI

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
5%Bearish
Buy/Sell Ratio100% buys
BearishBullish
UTI Live QuoteReal-time
$22.04
+$1.45(+7.04%)1M
Day Range$21.53 – $22.52
Open$21.93
Previous Close$21.86
Volume1.80M
Key Financials & Valuation
Fundamental balance sheet & market metrics
CONSUMER DEFENSIVE
Market Cap$1.20B
P/E Ratio (TTM)35.8
Forward P/E29.9
EPS (TTM)$0.61
Price to Book3.6
Dividend Yield0.65%
Beta (Volatility)1.21
IndustryEDUCATION & TRAINING SERVICES
52-Week RangeCurrent: $22.04 (12%)
Low: $18.02High: $51.34
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$38.33-74.4% upside

Insider Buys

1

$20K

Insider Sales

0

$0

Total Volume

$20K

36 transactions

Net Activity

+$20K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
65CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys35 sells

$8597.38B total

D
2

Devincenzi Robert Thomas

Dir

1 buys0 sells

$20K total

Trading History
UTI insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 28, 2026

1 months ago

Devincenzi Robert Thomas

Dir

Director
Buy1.0K$19.68$20K

Sep 21, 2026

1 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell152.3K$1000.00$152.33M

Aug 27, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell151.3K$1000.00$151.33M

Aug 25, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell150.3K$1000.00$150.33M

Aug 12, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell149.3K$1000.00$149.33M

Aug 10, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell148.3K$8000.00$1.19B

Jun 29, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell335.7K$-94500.00$0

Jun 22, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell27.0K$-4545.00$0

Jun 8, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell971.4K$-3000000.00$0

Jun 5, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell43.0K$-3500.00$0

May 11, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell127.6K$-15000.00$0

Mar 27, 2026

7 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell83.5K$-23654.00$0

Mar 6, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell19.8K$-10000.00$0

May 12, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell170.6K$-50000.00$0

Mar 4, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell104.1K$-16500.00$0

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell166.8K$-52671.00$0

Feb 27, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell430.2K$-60040.00$0

Feb 13, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell30.3K$-1750.00$0

Dec 3, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell7.54M$547066.00$4124.60B

Dec 1, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell6.31M$708107.00$4469.62B

Aug 12, 2025

15 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell136.8K$10000.00$1.37B

May 27, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell2.72M$-500000.00$0

May 15, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell80.5K$-27500.00$0

May 13, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell32.5K$-6000.00$0

Apr 15, 2025

19 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell134.1K$-97.00$0

Apr 9, 2025

19 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell134.2K$-208.00$0

Mar 17, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell194.1K$-70000.00$0

Mar 27, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell5.15M$-1000000.00$0

Mar 21, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell157.7K$-10000.00$0

Mar 19, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell167.7K$-49695.00$0

Feb 26, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell34.9K$-8000.00$0

Feb 10, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell6.15M$-704881.00$0

Dec 2, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell6.85M$-2483579.00$0

Nov 27, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell128.2K$-30000.00$0

Nov 26, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell134.7K$-30000.00$0

Nov 25, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell122.5K$-150000.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
UTI Buy Conviction100%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$15.24B

UTI has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for UTI

Over the last 90 days, corporate insiders at UTI (UTI) engaged in a total of 36 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $20K.

The net insider activity for UTI shows a net buying bias of $20K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 6.31M shares valued at $4469.62B on Dec 1, 2025.

Live Market News & Developments
Aggregated real-time headlines for UTI (UTI)
6 updates

Universal Technical Institute (UTI) Q4 Earnings Miss Estimates

Yahoo Finance7h ago

What Universal Technical Institute (UTI) Said on Its Q4 Earnings Call

Yahoo Finance3h ago

Complicated UTI Care Strained by Unclear Goals, Access Gaps

The American Journal of Managed Care7h ago

Universal Technical Institute I (UTI) Stock Forecasts

Yahoo Finance51m ago

Universal Technical Institute (UTI) Releases Q4 2026 Earnings: Revenue Growth but Misses Estimate

Quiver Quantitative7h ago

Universal Technical Institute Fiscal Q4 Earnings Fall, Revenue Rises; Shares Drop After Hours

marketscreener.com7h ago

Related News & Analyst Reports

Read original insights and educational research covering UTI and the Unknown sector.

August 6, 2026

The AI Circular Valuation Bubble: Inside the Venture-Cloud Loop

An in-depth investigation into how technology giants and AI startups engage in circular capital flows, investing venture capital in exchange for cloud services and hardware, creating a closed-loop economy that artificially inflates valuations.

Read Analysis
August 5, 2026

The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings

An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.

Read Analysis
August 4, 2026

The Spinoff Separation: Tracking Post-Spinoff Executive Ownership Trends

An investigation of corporate spinoffs, showing how executive equity allocations and post-separation insider transactions signal parent and subsidiary performance trajectories.

Read Analysis
August 3, 2026

The Lockup Expiration Wave: Venture Capital Post-IPO Exit Strategies

A data-driven analysis of how venture capital firms and pre-IPO insiders manage lockup expirations, detailing block trade execution, distribution methods, and stock price impact.

Read Analysis
July 17, 2026

a16z Capital Distributions vs. Open-Market Insider Buying: A 2026 Study

A 2026 empirical study comparing Andreessen Horowitz's in-kind share distributions to LPs against open-market insider purchases, revealing which signal better predicts 12-month price performance.

Read Analysis
May 28, 2026

Institutional Ownership vs. Insider Trading: Understanding the Data Flow

High institutional ownership reduces information asymmetry, but does it also reduce the predictive power of insider trades? This analysis tests whether stocks with more than 70% institutional ownership show weaker Form 4 signal performance.

Read Analysis

FAQs About UTI Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for UTI.

Based on SEC Form 4 disclosures, the Insider Confidence Score for UTI is currently 65/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for UTI is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.